Cell Therapeutics, Inc. (CTIC) Release: New EXTEND Analyses Evaluate Efficacy of Single Agent PIXUVRI® in 3rd and 4th Line Salvage Setting With and Without Prior Rituximab Treatment
6/17/2013
More...
|
Orexo AB Release: First Patient Dosed in New Phase III Study Targeted Towards a Future Clinical Indication Expansion for Zubsolv
6/17/2013
More...
|
NPS Pharmaceuticals, Inc. (NPSP) Release: Initial Findings from PARADOX, Largest and Most Comprehensive Research Analyzing the Burden of Hypoparathyroidism, Reveals Collection of Nearly 40 Physical, Cognitive, Emotional Symptoms
6/17/2013
More...
|
Orexo AB: First Patient Dosed in New Phase III Study Targeted Towards a Future Clinical Indication Expansion for Zubsolv
6/17/2013
More...
|
MannKind Corporation (MNKD) Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 2 Diabetes
6/17/2013
More...
|
Incyte Corporation (INCY) Drug Jakafi® (ruxolitinib) Improved Overall Survival in Phase III Trial of Patients With Myelofibrosis
6/17/2013
More...
|
Gilead Sciences, Inc. (GILD) Announces Interim Phase 2 Data for Idelalisib Showing Response in Refractory Indolent Non-Hodgkin's Lymphoma
6/17/2013
More...
|
Cell Therapeutics, Inc. (CTIC) Announces New Data Presented at EHA 2013 Congress Demonstrating the Safety and Tolerability Profile of Pacritinib in Patients With Myelofibrosis
6/17/2013
More...
|
Acetylon Pharmaceuticals Presents Encouraging Safety and Clinical Response Data from Ongoing Clinical Trials of ACY-1215 for the Treatment of Multiple Myeloma
6/17/2013
More...
|
NPS Pharmaceuticals, Inc. (NPSP) Release: Findings Presented at ENDO 2013 Support Therapeutic Potential of Natpara® as Parathyroid Hormone Replacement Therapy in Patients With Hypoparathyroidism
6/17/2013
More...
|
Versartis, Inc. Presents Positive Results From Its First Pediatric Clinical Study of Novel Long-Acting Growth Hormone Treatment at ENDO Annual Meeting
6/17/2013
More...
|
Array BioPharma, Inc. (ARRY) Announces Positive Interim Results From Combination Trial of ARRY-520 With Kyprolis at the 2013 European Hematology Association Congress
6/17/2013
More...
|
AbbVie (ABBV) Presents Preliminary Results From Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
6/17/2013
More...
|
Boehringer Ingelheim Corporation Release: New Long-Term Data Reinforce Safety Profile of Pradaxa® for Stroke Prevention in AF
6/17/2013
More...
|
Celgene International Sárl (CELG) Oral Anti-Cancer Therapy REVLIMID® (lenalidomide) Now Indicated as a Treatment for Patients With Rare Form of Blood Disease
6/17/2013
More...
|
Kowa Pharmaceuticals America Release: New Data Showed LIVALO® (pitavastatin) 4 mg had Neutral Effects on Fasting Serum Glucose and HbA1c Levels in HIV-infected Adults with Dyslipidemia
6/17/2013
More...
|
Pharmavite Release: Daily 10 Milligram Dose of S-Equol Reduces Menopausal Symptoms Effectively Without Impacting Thyroid and Sex Hormones
6/17/2013
More...
|
R-Biopharm Rhone Supports Glasgow Caledonian Study Into Mycotoxins in Ethnic Shops
6/17/2013
More...
|
AstraZeneca Canada Inc. (AZN) Release: Real-World Evidence Shows Importance of Treatment Choice in Risk of COPD Related Pneumonia
6/17/2013
More...
|
Imprimis Pharmaceuticals (immy) Acquires Intellectual Property Assets From Buderer Drug Company
6/17/2013
More...
|
Ambrx, Inc. and Zhejiang Medicine Co. Ltd. Form Collaboration to Develop and Commercialize Ambrx's Antibody Drug Conjugate for Breast Cancer
6/17/2013
More...
|
Summit Corporation Achieves Clinical Milestone Triggering £740,000 Payment From Wellcome Trust to Fund Novel C. Difficile Antibiotic
6/17/2013
More...
|
Genmab A/S (GEN.CO) and ADC Therapeutics Enter Co-Development Collaboration for an Antibody-Drug Conjugate Combining HuMax-TAC and PBD Warhead
6/17/2013
More...
|
Siemens Healthcare Diagnostics to Create Companion Diagnostic Test for In-Development Janssen Heart Failure Drug
6/17/2013
More...
|
PsychoGenics Inc. and Sunovion Pharmaceuticals Inc. Expand Their Drug Discovery Partnership
6/17/2013
More...
|
BioClinica, Inc. Announces Completion of the First Thorough QT Study in China and a Strategic Partnership With TEDA International Cardiovascular Hospital (TICH)
6/17/2013
More...
|
Ambrx, Inc. and Zhejiang Medicine Co. Ltd. Form Collaboration to Develop and Commercialize Ambrx's Antibody Drug Conjugate for Breast Cancer
6/17/2013
More...
|
EU Grants EUR 6M to the Clinical Development of Athera Biotechnologies's Cardiovascular Disease Antibody Therapy
6/17/2013
More...
|
Karolinska Development AB: EU Grants EUR 6 Million to the Clinical Development of Athera Biotechnologies' Cardiovascular Disease Antibody Therapy
6/17/2013
More...
|
Takeda Pharmaceutical Co. Ltd. (TKPYY) Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States
6/17/2013
More...
|
Amedra Pharmaceuticals Markets Adrenaclick® Auto-Injector
6/17/2013
More...
|
NeoStem, Inc. Announces Geographic Expansion of Intellectual Property Coverage of AMR-001 to Canada
6/17/2013
More...
|
Rexahn Pharmaceuticals, Inc. Awarded U.S. Patent for Novel Anti-Cancer Compounds
6/17/2013
More...
|
Medicago, Inc. Granted Patent for Influenza Virus-Like Particles in Plants
6/17/2013
More...
|
Trigemina Attracts $4.5 Million Funding From Current Investors and Chilean Government Grant
6/17/2013
More...
|
Onconova Therapeutics Inc. Files Registration Statement for Proposed Initial Public Offering of Common Stock
6/17/2013
More...
|
VIVUS, Inc. (VVUS) Urges Stockholders to Support the Board of Directors and Management Team at This Critical Time
6/17/2013
More...
|
Advaxis, Inc. Announces Voting Results of 2013 Annual Meeting of Stockholders
6/17/2013
More...
|
Source BioScience Launches New Overnight Service for DNA Sequencing for Scotland
6/17/2013
More...
|
ICON-PLC (ICLR) and University College Dublin Launch Innovative Graduate Certificate in Clinical Research
6/17/2013
More...
|
NovaBay Pharmaceuticals, Inc. (NBY) Supports Legislation to Attack Antibiotic Resistance
6/17/2013
More...
|
Cell Therapeutics, Inc. (CTIC) to Join Russell 3000® and Russell Global Indexes
6/17/2013
More...
|
Amicus Therapeutics, Inc. (FOLD) to Host Conference Call Today at 8:00 a.m. ET to Discuss Regulatory Strategy for Migalastat HCl Monotherapy for Fabry Disease
6/17/2013
More...
|
Royalty Pharma Chairman Writes Open Letter to Elan Corporation PLC (ELN) Board
6/17/2013
More...
|
PAREXEL International (PRXL) Invites Public to Listen to Live Webcast of Its Investor Day June 26, 2013
6/17/2013
More...
|
Intercept Pharmaceuticals Announces Proposed Public Offering of Common Stock
6/17/2013
More...
|
Clontech Laboratories, Inc. Release: Clinical Grade RetroNectin® Reagent Available to Support Gene Therapy Clinical Research
6/17/2013
More...
|
Royalty Pharma Informs Elan Corporation PLC (ELN) Stockholders About the Consequences Arising From the Results of the Elan EGM Earlier Today
6/17/2013
More...
|
InSite Vision (ISV) Announces Joint Patent Infringement Lawsuit With Merck & Co., Inc. (MRK) Against Mylan Pharmaceuticals, Inc. (MYL)
6/17/2013
More...
|
European Medicines Agency's Management Board Endorses Revised EMA Code of Conduct
6/17/2013
More...
|
Agilent Technologies Inc. (A) Announces Broad Institute as Early Adopter of Encore Multispan Liquid-Handling System
6/17/2013
More...
|
Albany Molecular Research, Inc. (AMRI) (AMRI) Promotes Susan Collins to Director, Business Development
6/17/2013
More...
|
Emergent BioSolutions (EBS) EVP Corporate Affairs Allen Shofe Appointed to MdBio Foundation Board of Directors
6/17/2013
More...
|
MdBio Foundation Names New Board Members
6/17/2013
More...
|
QPharma, Inc. Appoints Senior Manager, Healthcare Compliance
6/17/2013
More...
|
Santarus Inc. (SNTS) President & CEO Gerald Proehl Honored as San Diego Ernst & Young LLP Entrepreneur of the Year 2013 in Life Sciences
6/17/2013
More...
|
Tauriga Sciences Inc. (TAUG) to Commence Presentations to Key Distribution Groups in the Southeast United States for the Conversion to "100% Tree-Free" Biodegradable Products to the Hospitals They Supply
6/17/2013
More...
|
TopoTarget A/S Release: Positive Subtype Data From the BELIEF Trial Presented at the 12th International Conference on Malignant Lymphoma
6/17/2013
More...
|
VIVUS, Inc. (VVUS) Announces Scientific Presentations
6/17/2013
More...
|
BIOTECanada and BioTalent Canada Announce Partnership to Strengthen Canada’s Bio-Economy
6/17/2013
More...
|
Waters Corporation (WAT) Presentation at the Wells Fargo Securities 2013 Healthcare Conference to Be Audio Webcast Live
6/17/2013
More...
|
Elcelyx Therapeutics to Present Clinical Data on NewMet™ in Type 2 Diabetes at the 2013 American Diabetes Association Scientific Sessions
6/17/2013
More...
|
Biodel Inc. (BIOD) Announces Data Presentations at American Diabetes Association Annual Meeting
6/17/2013
More...
|
Zealand Pharma Informs of New Sanofi (France) (SAN.PA) Scientific Presentations for Lyxumia® and of Own Presentation of a Novel Zealand Liquid Glucagon Analogue at the American Diabetes Association’s 73rd Scientific Sessions
6/17/2013
More...
|
TG Therapeutics, Inc. (MHA) Announces Clinical and Pre-Clinical Poster Presentations for TG-1101 and TGR-1202 at the European Hematology Association Meeting in Stockholm, Sweden
6/17/2013
More...
|
Merus Presents Preclinical Data on Its Novel Bispecific Antibody MCLA-117 at European Hematology Association 2013
6/17/2013
More...
|
Mid-Atlantic Biotech Leaders Featured on BioSpace Map
6/17/2013
More...
|